المؤلفون: Christian U. Blank, Adil Daud, Rene Gonzalez, Kim Margolin, Scot Ebbinghaus, Ziwen Wei, Dirk Schadendorf, Antoni Ribas, Anna C. Pavlick, Lee D. Cranmer, Caroline Robert, April K.S. Salama, Jacob Schachter, Omid Hamid, Reinhard Dummer, Nageatte Ibrahim, F. Stephen Hodi, Igor Puzanov, Tara C. Gangadhar, Paolo A. Ascierto

المساهمون: University of Zurich, Hamid, Omid

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Medizin, Phases of clinical research, Pembrolizumab, Kaplan-Meier Estimate, 0302 clinical medicine, Antineoplastic Agents, Immunological, 1306 Cancer Research, Melanoma, Aged, 80 and over, education.field_of_study, Cross-Over Studies, Drug Substitution, Hazard ratio, 10177 Dermatology Clinic, Middle Aged, MAP Kinase Kinase Kinases, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, 2730 Oncology, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Adolescent, Population, Ipilimumab, 610 Medicine & health, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, education, Protein Kinase Inhibitors, Aged, Chemotherapy, business.industry, medicine.disease, Confidence interval, Surgery, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, business

وصف الملف: 721_Hamid_O._et_al._Final_analysis_of_randomised_trial_comparing_pembrolizumab_versus_Eur_J_Cancer_2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab24a3779538f584d0432f320113cbb5Test
https://www.ncbi.nlm.nih.gov/pubmed/28961465Test

المؤلفون: Adil Daud, Richard W. Joseph, Xiaoyun Nicole Li, Marisa Dolled-Filhart, Amita Patnaik, Grant Toland, Roxana S. Dronca, Wen-Jen Hwu, Charlotte Roach, Tara C. Gangadhar, Caroline Robert, Omid Hamid, Richard F. Kefford, Antoni Ribas, S. Peter Kang, Scot Ebbinghaus, Peter Hersey, Hassane M. Zarour, Anthony M. Joshua, Jared Lunceford, F. Stephen Hodi, Jedd D. Wolchok, Kenneth Emancipator, Jeffrey S. Weber

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 34, iss 34

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Pathology, Programmed Cell Death 1 Receptor, Pembrolizumab, B7-H1 Antigen, 0302 clinical medicine, Monoclonal, 80 and over, Humanized, Melanoma, Cancer, Aged, 80 and over, Tumor, Predictive marker, Middle Aged, Immunohistochemistry, Survival Rate, Treatment Outcome, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, Adolescent, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Antibodies, Drug Administration Schedule, 03 medical and health sciences, Clinical Research, Internal medicine, Original Reports, medicine, Biomarkers, Tumor, Humans, Oncology & Carcinogenesis, Survival rate, Aged, Neoplasm Staging, business.industry, medicine.disease, Brain Disorders, Clinical trial, 030104 developmental biology, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c5df28bbc8ca5d8eb2e63f58ce73f9cTest
https://pubmed.ncbi.nlm.nih.gov/27863197Test

المؤلفون: Alexis Mathian, Caroline Robert, Celine Boutros, Hassan Izzedine, Philippe Rouvier, Zahir Amoura, Christine Mateus

المصدر: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 32(6)

مصطلحات موضوعية: Cell cycle checkpoint, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 030232 urology & nephrology, Ipilimumab, Pembrolizumab, Kidney, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Adrenal Cortex Hormones, Neoplasms, medicine, Animals, Humans, CTLA-4 Antigen, Transplantation, business.industry, Immunotherapy, Acute Kidney Injury, Immune checkpoint, medicine.anatomical_structure, Nephrology, 030220 oncology & carcinogenesis, Immune System, Cancer research, Nivolumab, business, Tremelimumab, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5bc8c691c41b3dd6c1975e34f3f5bbbTest
https://pubmed.ncbi.nlm.nih.gov/28025384Test

المؤلفون: Scot Ebbinghaus, Christian U. Blank, Omid Hamid, James Larkin, Catriona M. McNeil, Adil Daud, Michal Lotem, Nageatte Ibrahim, Teresa M. Petrella, Caroline Robert, Jean-Jacques Grob, Laurent Mortier, Paul Lorigan, Georgina V. Long, Bart Neyns, Antoni Ribas, Matteo S. Carlino, Jacob Schachter, Ana Arance, Honghong Zhou

المساهمون: Laboratory of Molecullar and Cellular Therapy, Laboratory of Molecular and Medical Oncology, Clinical sciences

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ipilimumab, Pembrolizumab, Surgery, Lower incidence, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Overall survival, Medicine, business, medicine.drug, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fc4539892dd1d07be846517f3d2e05Test
https://biblio.vub.ac.be/vubirTest/pembrolizumab-versus-ipilimumab-for-advanced-melanoma-final-overall-survival-analysis-of-keynote006(2e1d8a74-0d96-4455-b3cc-da5df5908b2c).html

المؤلفون: Clemens Krepler, Jean-Jacques Grob, Nageatte Ibrahim, Caroline Robert, James Larkin, Ana Arance, Jared Lunceford, Andrea L. Webber, Antoni Ribas, Jacob Schachter, Georgina V. Long, Wendy M. Blumenschein, Razvan Cristescu, Matteo S. Carlino, Chunsheng Zhang, Qing Zhao, Adil Daud, Michael Nebozhyn

المصدر: Cancer Research. 79:4217-4217

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, T cell, Cancer, Pembrolizumab, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Internal medicine, PD-L1, Gene expression, medicine, biology.protein, Biomarker (medicine), Progression-free survival, business, Exome

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::36940ebae65e75e380f5177e8446f973Test
https://doi.org/10.1158/1538-7445.am2019-4217Test

المؤلفون: Christian U. Blank, Michal Lotem, Clemens Krepler, Teresa M. Petrella, Matteo S. Carlino, Caroline Robert, Georgina V. Long, Paul Lorigan, Antoni Ribas, James Larkin, Omid Hamid, Laurent Mortier, Jean-Jacques Grob, James R. Anderson, Catriona M. McNeil, Scott J. Diede, Bart Neyns, Ana Arance, Jacob Schachter, Adil Daud

المصدر: Cancer Research. 79:CT188-CT188

مصطلحات موضوعية: 0301 basic medicine, Antitumor activity, Cancer Research, medicine.medical_specialty, business.industry, Best Overall Response, Ipilimumab, Pembrolizumab, Gastroenterology, Discontinuation, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Internal medicine, Long term outcomes, Effective treatment, Medicine, business, Advanced melanoma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e661b8df1aa2a3a4b30d41105ca8b8e8Test
https://doi.org/10.1158/1538-7445.am2019-ct188Test

المؤلفون: Jeffrey E. Gershenwald, Merrick I. Ross, Nageatte Ibrahim, Charles H. Yoon, Vernon K. Sondak, Jean-Jacques Grob, Piotr Rutkowski, John M. Kirkwood, Alexander M.M. Eggermont, Andrew Poklepovic, Jason J. Luke, Richard A. Scolyer, Georgina V. Long, Sama Ahsan, Peter Mohr, James R. Anderson, Matteo S. Carlino, Caroline Robert, Axel Hauschild, Paolo A. Ascierto

المصدر: Journal of Clinical Oncology. 37:TPS9596-TPS9596

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Placebo, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Stage II melanoma, Adjuvant therapy, Medicine, In patient, Stage III melanoma, business, Adjuvant, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dfd1a33d37748bae5890bfaca892ce80Test
https://doi.org/10.1200/jco.2019.37.15_suppl.tps9596Test

المؤلفون: Andrew G. Hill, Steven J. O'Day, Stéphane Dalle, Marcus O. Butler, Victoria Atkinson, Jonathan Cebon, Alexander M. Menzies, Blanca Homet Moreno, Steven L. McCune, Nageatte Ibrahim, Caroline Robert, Félix Couture, Matteo S. Carlino, Cuizhen Niu, Geoffrey T. Gibney, Georgina V. Long, Michael P. Brown, Adi Diab

المصدر: Journal of Clinical Oncology. 37:9514-9514

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Toxicity, Cohort, medicine, Nivolumab, business, 030215 immunology, Advanced melanoma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2651b0497437c58c78ae468efd3b99d8Test
https://doi.org/10.1200/jco.2019.37.15_suppl.9514Test

المؤلفون: Mario Mandalà, Andrew Haydon, Stéphane Dalle, Matteo S. Carlino, Paolo A. Ascierto, Christian U. Blank, Victoria Atkinson, Muhammad A. Khattak, Michal Kicinski, Susana Puig, Mikhail Lichinitser, Alexander C.J. van Akkooi, Shahneen Sandhu, Alexander M.M. Eggermont, Stefan Suciu, Nageatte Ibrahim, Georgina V. Long, Clemens Krepler, Caroline Robert, Sandrine Marreaud

المصدر: Journal of Clinical Oncology. 37:2517-2517

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Immunotherapy, Placebo, Predictive value, 03 medical and health sciences, 0302 clinical medicine, Immune system, 030220 oncology & carcinogenesis, Internal medicine, medicine, Stage III melanoma, business, Adverse effect, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::79a17e7e77f0a48b2afc7ced78dc55f9Test
https://doi.org/10.1200/jco.2019.37.15_suppl.2517Test

المؤلفون: Jean-Jacques Grob, Peter Mohr, Andrew Poklepovic, Richard A. Scolyer, Jason J. Luke, Vernon K. Sondak, Jeffrey E. Gershenwald, James R. Anderson, Matteo S. Carlino, Caroline Robert, John M. Kirkwood, Nageatte Ibrahim, Charles H. Yoon, Georgina V. Long, Alexander M.M. Eggermont, Sama Ahsan, Axel Hauschild, Paolo A. Ascierto, Merrick I. Ross

المصدر: Journal of Clinical Oncology. 37:TPS145-TPS145

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Placebo, Stage II melanoma, Internal medicine, medicine, Adjuvant therapy, Stage III melanoma, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::12cb82cf6dd4d9636fb43dbb994f2112Test
https://doi.org/10.1200/jco.2019.37.8_suppl.tps145Test